SAMSUNG PHARM. Co., LTD.
KRX:001360.KS
1,515 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SAMSUNG PHARM. Co., LTD. |
Symbool | 001360.KS |
Munteenheid | KRW |
Prijs | 1,518 |
Beurswaarde | 142,874,641,206 |
Dividendpercentage | 0% |
52-weken bereik | 1,453 - 2,869.12 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Won-Kyu Kim |
Website | https://www.sspharm.co.kr |
An error occurred while fetching data.
Over SAMSUNG PHARM. Co., LTD.
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)